SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-029270
Filing Date
2022-03-02
Accepted
2022-03-02 16:07:06
Documents
1
Group Members
BENGT JULANDER

Document Format Files

Seq Description Document Type Size
1 SC 13G tm228194-1_sc13g.htm SC 13G 62645
  Complete submission text file 0001104659-22-029270.txt   64139
Mailing Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Subject) CIK: 0001795579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91523 | Film No.: 22703460
SIC: 2834 Pharmaceutical Preparations

Mailing Address CRONHAMNS GATA 6A 185 32 VAXHOLM VAXHOLM V7 185 32
Business Address CRONHAMNS GATA 6A 185 32 VAXHOLM VAXHOLM V7 185 32 01146703195909
Linc AB (Filed by) CIK: 0001815314 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC 13G